Home / SORCS2 Knockout Cell Lines

SORCS2 Knockout Cell Lines

Gene: SORCS2

Official Full Name: sortilin related VPS10 domain containing receptor 2provided by HGNC

Gene Summary: This gene encodes one family member of vacuolar protein sorting 10 (VPS10) domain-containing receptor proteins. The VPS10 domain name comes from the yeast carboxypeptidase Y sorting receptor Vps10 protein. Members of this gene family are large with many exons but the CDS lengths are usually less than 3700 nt. Very large introns typically separate the exons encoding the VPS10 domain; the remaining exons are separated by much smaller-sized introns. These genes are strongly expressed in the central nervous system. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO04803 SORCS2 Knockout cell line (HeLa) Human SORCS2 1:3~1:6 Negative Online Inquiry
KO04804 SORCS2 Knockout cell line (A549) Human SORCS2 1:3~1:4 Negative Online Inquiry

Background

SORCS2 Gene Knockout Cell Lines are genetically modified cell lines in which the SORCS2 gene has been precisely disrupted through advanced CRISPR-Cas9 technology. SORCS2, or Sortilin-related VPS10-domain containing receptor 2, is implicated in various cellular processes, including neurodevelopment and synaptic function, making these cell lines invaluable for studying its role in health and disease.

These knockout cell lines function by eliminating the expression of SORCS2, allowing researchers to observe phenotypic changes and altered signaling pathways. By providing an unambiguous model of SORCS2 deficiency, scientists can investigate its contributions to neurodegenerative conditions, psychiatric disorders, and developmental abnormalities. The ability to study these processes in vitro facilitates a better understanding of potential therapeutic targets and disease mechanisms.

Significantly, SORCS2 Gene Knockout Cell Lines offer a robust platform for research and drug development, with applications ranging from basic neuroscience to translational medicine. They enable high-throughput screening of compounds for potential therapeutic effects in SORCS2-related pathologies. Compared to other genetic manipulation techniques, the precision and efficiency of CRISPR-Cas9 ensure stable and heritable gene knockout, providing researchers with reliable and reproducible results.

The value of SORCS2 Gene Knockout Cell Lines lies in their ability to provide clarity on the functional role of SORCS2, enhancing our understanding of complex biological systems. This product caters to researchers and clinicians who are at the forefront of investigating genetic influences on health, guiding the potential development of targeted therapies.

Our company specializes in the creation and enhancement of biological research tools, backed by extensive experience and a commitment to quality. By choosing SORCS2 Gene Knockout Cell Lines, you are investing in a product designed to empower scientific discovery and advance your research endeavors.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.